mRNA eReport: therapeutic market and technology trend

mRNA is a versatile technology that can be used to target a wide range of diseases. As of June 2023, it is showing promise in vaccines for a range of viruses, including influenza, Ebola, and HIV. It is also being investigated as a treatment for chronic illness like cancer, heart disease, and rare diseases. But there are challenges that still need to be addressed before mRNA can reach its full potential.

Reported in this asset, developed by Drug Discovery World (DDW) and sponsored by Thermo Fisher Scientific, are:

Trend: The global market for mRNA vaccines and therapeutics
New frontiers: What’s next for mRNA technology?
Interview: Insights on the potential of mRNA vaccines and therapeutics
The future: Is there a role for mRNA in the treatment of cancer?

First name

Last name

Company / institution

Country / region

City

Phone number

What is your current stage of mRNA production? In early stages (research & discovery) Investigating solutions Actively establishing Already performing Not working in mRNA production

Would you like to discuss options for mRNA raw materials with our representative? Yes, I’d like to be contacted. No, I’m here for learning

I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates:

By email

By telephone

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing my personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.

I can choose to unsubscribe at any time by e-mailing reply@thermofisher.com

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.

eReport: mRNA therapeutic market and the technology future